Engineering a pure and stable heterodimeric IgA for the development of multispecific therapeutics
Immunoglobulin G (IgG) has served as a traditional framework for antibody-based biology, and engineering approaches for creating multispecific therapeutics have greatly expanded its applicability. Despite these developments, there are limits to the functionality of IgG with respect to effector cells...
Saved in:
Main Authors: | Florian Heinkel (Author), Meghan M. Verstraete (Author), Siran Cao (Author), Janessa Li (Author), Patrick Farber (Author), Elizabeth Stangle (Author), Begonia Silva-Moreno (Author), Fangni Peng (Author), Surjit Dixit (Author), Martin J. Boulanger (Author), Thomas Spreter Von Kreudenstein (Author), Eric Escobar-Cabrera (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developability considerations for bispecific and multispecific antibodies
by: Alaa Amash, et al.
Published: (2024) -
Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
by: Meghan M. Verstraete, et al.
Published: (2023) -
"Stapling" scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023) -
Functional Consequences of GPCR Heterodimerization: GPCRs as Allosteric Modulators
by: Karla K.V. Haack, et al.
Published: (2011) -
Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
by: Rishi K. Somvanshi, et al.
Published: (2012)